カテゴリ： MarketLine, イギリス, 企業調査

Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務情報

◆英語タイトル：Hikma Pharmaceuticals PLC - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1941
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：49
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report
Summary

Hikma Pharmaceuticals PLC – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Hikma Pharmaceuticals (Hikma or ‘the company’) is engaged in the development, manufacturing and marketing of generic and in-licensed pharmaceutical products. The company offers diversified product portfolio and pipeline across a broad range of therapeutic categories including: anti-infectives, cardiovascular, central nervous system, diabetes, oncology, pain management and respiratory. It offers its products in various dosage forms including tablets, capsules, solutions and suspensions. The company markets its products under brands such as Amoclan, Blopress, Suprax , Omnicef, Prograf, Suprax and Cresemba. Hikma sells its products through leading wholesalers, pharmacy chains, governments and hospital purchasing organisations. The company primarily operates in the Middle East and North Africa (MENA), the US and Europe. Hikma is headquartered in London, the UK.

Scope

- Detailed information on Hikma Pharmaceuticals PLC required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Hikma Pharmaceuticals PLC in the form of a SWOT analysis
- An in-depth view of the business model of Hikma Pharmaceuticals PLC including a breakdown and examination of key business segments
- Intelligence on Hikma Pharmaceuticals PLC’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Hikma Pharmaceuticals PLC, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Hikma Pharmaceuticals PLC and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Hikma Pharmaceuticals PLC as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Hikma Pharmaceuticals PLC’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Hikma Pharmaceuticals PLC: Company Overview 9
Hikma Pharmaceuticals PLC: Overview and Key Facts 9
Hikma Pharmaceuticals PLC: Overview 9
Hikma Pharmaceuticals PLC: Key Facts 9
Hikma Pharmaceuticals PLC: Key Employees 11
Hikma Pharmaceuticals PLC: Key Employee Biographies 13
Hikma Pharmaceuticals PLC: Major Products and Services 16
Hikma Pharmaceuticals PLC: Company History 17
Hikma Pharmaceuticals PLC: Management Statement 21
Hikma Pharmaceuticals PLC: Locations and Subsidiaries 24
Hikma Pharmaceuticals PLC: Key Competitors 25
Hikma Pharmaceuticals PLC: Company Analysis 26
Hikma Pharmaceuticals PLC: Business Description 26
Hikma Pharmaceuticals PLC: SWOT Analysis 28
Hikma Pharmaceuticals PLC: SWOT Overview 28
Hikma Pharmaceuticals PLC: Strengths 28
Hikma Pharmaceuticals PLC: Weaknesses 29
Hikma Pharmaceuticals PLC: Opportunities 29
Hikma Pharmaceuticals PLC: Threats 30
Hikma Pharmaceuticals PLC: Corporate Financial Deals Activity 31
Hikma Pharmaceuticals PLC: Financial Deals Overview 31
Hikma Pharmaceuticals PLC: Targets and Partners 33
Hikma Pharmaceuticals PLC: Top Deals 2014 – 2018YTD* 34
Hikma Pharmaceuticals PLC: Advisors 35
Hikma Pharmaceuticals PLC: Top Legal Advisors 35
Hikma Pharmaceuticals PLC: Top Financial Advisors 35
Hikma Pharmaceuticals PLC: Mergers and Acquisitions 36
Hikma Pharmaceuticals PLC: Partnership 37
Hikma Pharmaceuticals PLC: Divestments 38
Hikma Pharmaceuticals PLC: Recent Developments 39
Hikma Pharmaceuticals PLC: News and Events Summary 39
Hikma Pharmaceuticals PLC: Business Expansion 42
Hikma Pharmaceuticals PLC: Corporate Governance 42
Hikma Pharmaceuticals PLC: Financial Deals 44
Hikma Pharmaceuticals PLC: Financial Performance 44
Hikma Pharmaceuticals PLC: Research & Development 45
Hikma Pharmaceuticals PLC: Strategy and Operations 45
Appendix 47
Contact Us 47
Methodology 47
About MarketLine 48

List of Tables
Table 1: Hikma Pharmaceuticals PLC: Key Facts
Table 2: Hikma Pharmaceuticals PLC: Key Employees
Table 3: Hikma Pharmaceuticals PLC: Locations and Subsidiaries
Table 4: Hikma Pharmaceuticals PLC: Key Competitors
Table 5: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Table 8: Hikma Pharmaceuticals PLC: Targets and Partners
Table 9: Hikma Pharmaceuticals PLC: Top Deals 2014 - 2018YTD*
Table 10: Hikma Pharmaceuticals PLC: Legal Advisor Ranking by Value (US$m)
Table 11: Hikma Pharmaceuticals PLC: Financial Advisor Ranking by Value (US$m)
Table 12: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2014 - YTD*2018)
Table 14: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 15: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 16: Hikma Pharmaceuticals PLC: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 17: Hikma Pharmaceuticals PLC: News and Events Summary
Table 18: Hikma Pharmaceuticals PLC: Business Expansion
Table 19: Hikma Pharmaceuticals PLC: Corporate Governance
Table 20: Hikma Pharmaceuticals PLC: Financial Deals
Table 21: Hikma Pharmaceuticals PLC: Financial Performance
Table 22: Hikma Pharmaceuticals PLC: Research & Development
Table 23: Hikma Pharmaceuticals PLC: Strategy and Operations

List of Figures
Figure 1: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Hikma Pharmaceuticals PLC: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Hikma Pharmaceuticals PLC: M&A Average Deal Size - Value (US$m)
Figure 4: Hikma Pharmaceuticals PLC: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Hikma Pharmaceuticals PLC: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Hikma Pharmaceuticals PLC: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 7: Hikma Pharmaceuticals PLC: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 8: Hikma Pharmaceuticals PLC: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Hikma Pharmaceuticals PLC：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Kier Group plc：企業のM&A・事業提携・投資動向
    Kier Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kier Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • ManpowerGroup Inc (MAN)：企業の財務・戦略的SWOT分析
    ManpowerGroup Inc (MAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • eClinicalWorks LLC：企業の戦略的SWOT分析
    eClinicalWorks LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bellatrix Exploration Ltd (BXE)：石油・ガス：M&Aディール及び事業提携情報
    Summary Bellatrix Exploration Ltd (Bellatrix Exploration), formerly True Energy Inc, is an oil and gas that explores and produces light oil and liquids-rich natural gas in the Western Canada Sedimentary Basin. The company develops the Cardium and the Falher or Notikewin intervals in the Western Cana …
  • Taisei Corporation：企業の戦略・SWOT・財務分析
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PolyPid Ltd：製品パイプライン分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • Linamar Corporation：企業の戦略・SWOT・財務情報
    Linamar Corporation - Strategy, SWOT and Corporate Finance Report Summary Linamar Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Amneal Pharmaceuticals Inc (AMRX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • CASI Pharmaceuticals Inc (CASI)：製薬・医療：M&Aディール及び事業提携情報
    Summary CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of innovative therapies for treating cancer and other unmet medical needs. Its pipeline product portfolio includes ENMD-2076 that is being developed globally fo …
  • Sagent Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam f …
  • Telecom Italia S.p.A.：企業の戦略・SWOT・財務情報
    Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Laboratoire Aguettant SA：製薬・医療：M&Aディール及び事業提携情報
    Summary Laboratoire Aguettant SA (Aguettant) is a pharmaceutical company that that focuses on the development, manufacturing and commercialisation of injectable hospital medicines. The company offers sterile injectable medicines in various dosages and pharmaceutical forms. It provides its products f …
  • EnBW Energie Baden-Wurttemberg AG (EBK)-石油・ガス分野：企業M&A・提携分析
    Summary EnBW Energie Baden-Wuerttemberg AG (EnBW) is an integrated energy holding company that generates, procures, transmits and supplies electricity; and produces, transports and supplies gas through its subsidiaries. Its generation portfolio includes nuclear, coal, oil, gas, wind, and pumped stor …
  • Senzime AB (SEZI)：医療機器：M&Aディール及び事業提携情報
    Summary Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company's product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients …
  • Reliance Infrastructure Ltd (RELINFRA)：企業の財務・戦略的SWOT分析
    Reliance Infrastructure Ltd (RELINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • CHC Group Ltd：石油・ガス：M&Aディール及び事業提携情報
    Summary CHC Group Ltd (CHC) is a provider of helicopter services. The company offers various services including offshore transportation; search and rescue in challenging and hostile environments, from remote, perilous, and extreme terrains to offshore rescues; maintenance, repair, and overhaul; and …
  • Shandong Weigao Group Medical Polymer Company Ltd (1066)：企業の財務・戦略的SWOT分析
    Shandong Weigao Group Medical Polymer Company Ltd (1066) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company …
  • SPIE SA (SPIE)：企業の財務・戦略的SWOT分析
    SPIE SA (SPIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • AxoGen Inc (AXGN)：企業の財務・戦略的SWOT分析
    Summary AxoGen Inc (AxoGen), formerly LecTec Corp is a provider of surgical solutions to measure and monitor nerve functions. The company offers products such as AxoTouch two-point discriminator, AxoGuard nerve connector, Avance nerve graft, AcroVal NSTMS and AxoGuard nerve protector products, among …
  • CG Power and Industrial Solutions Ltd (CGPOWER)：企業の財務・戦略的SWOT分析
    CG Power and Industrial Solutions Ltd (CGPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆